Trimetazidine Dihydrochloride
ইঙ্গিত
Vastadin MR is used in adults as an add-on to first-line antianginal treatment. It is given to patients with stable angina pectoris whose symptoms are not adequately controlled by, or who cannot tolerate, those first-line therapies.
⚠️ কোনো ওষুধ গ্রহণের আগে সর্বদা নিবন্ধিত চিকিৎসকের পরামর্শ নিন।
ফার্মাকোলজি
Trimetazidine Dihydrochloride was the first 3-keto acyl CoA thiolase inhibitor (KAT) developed, a metabolic anti-ischaemic agent shown to benefit all coronary patients. It works by inhibiting the 3-keto acyl CoA thiolase enzyme, which blocks the fatty acid pathway and shifts the heart's energy production toward the glucose pathway instead. Because the glucose pathway generates energy more efficiently, the same amount of oxygen yields more energy, helping the heart work more actively. The aerobic breakdown of glucose also halts the buildup of lactic acid, which helps prevent angina pectoris.
Pregnancy & Breastfeeding
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
ডোজ নির্দেশিকা
⚠️ শুধুমাত্র সরকারি উৎস থেকে নির্দেশিকা পরিসীমা। ব্যক্তিগতকৃত ডোজের জন্য আপনার ডাক্তারের পরামর্শ নিন।
পার্শ্বপ্রতিক্রিয়া ও পারস্পরিক ক্রিয়া
পার্শ্বপ্রতিক্রিয়া
No side-effect data recorded yet.